SEC Form 4 · accession 0001246360-17-000416
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph E Turk Jr.
Officer — President
Period of report
Feb 2, 2017
Accepted (ET)
Feb 2, 2017 · 6:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 2, 2017 | M | 2,669 | $18.48 | A | 72,949 | D | |
| Common Stock | Feb 2, 2017 | M | 7,000 | $11.03 | A | 79,949 | D | |
| Common Stock | Feb 2, 2017 | M | 6,000 | $14.66 | A | 85,949 | D | |
| Common Stock | Feb 2, 2017 | S | 15,669 | $26.19 | D | 70,280 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $18.48 | Feb 2, 2017 | M | 2,669 | D | Apr 9, 2012 | Mar 8, 2019 | Common Stock | 2,669 | 10,211 | D |
| Stock Option (Right to Buy) | $11.03 | Feb 2, 2017 | M | 7,000 | D | Apr 4, 2013 | Mar 3, 2023 | Common Stock | 7,000 | 39,897 | D |
| Stock Option (Right to Buy) | $14.66 | Feb 2, 2017 | M | 6,000 | D | Apr 10, 2014 | Mar 9, 2024 | Common Stock | 6,000 | 54,958 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2016.